Status:
RECRUITING
Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Retinopathy of Prematurity Both Eyes
Retinal Disease
Eligibility:
All Genders
Up to 18 years
Phase:
PHASE4
Brief Summary
This study aims to study the safety and efficacy of using an 18 mm short vitrectomy probe for pediatric vitreoretinal surgeries and to investigate the surgeon's comfort and reliability of using the sh...
Detailed Description
With advancements in sutureless vitrectomy, more and more pediatric disease entities can be successfully coped with intraocular surgeries and with fewer complications. However, the pediatric eye is no...
Eligibility Criteria
Inclusion
- Patients less than 18 years old
- Need vitrectomy due to various etiologies, including retinopathy of prematurity, familial exudative vitreoretinopathy, persistent fetal vasculature, congenital cataract, lens dislocation, open-globe injury, vitreous hemorrhage, or other vitreoretinal diseases.
Exclusion
- Patients who cannot cooperate fully with detailed ophthalmic examinations.
Key Trial Info
Start Date :
March 5 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2028
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06520410
Start Date
March 5 2024
End Date
February 28 2028
Last Update
July 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chang Gung Memorial Hospital
Taoyuan District, Taiwan, 333